Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Bone Marrow Transplant 2023 Dec;58(12):1390-1393

Date

09/05/2023

Pubmed ID

37666957

Pubmed Central ID

PMC11221560

DOI

10.1038/s41409-023-02092-3

Scopus ID

2-s2.0-85169665242 (requires institutional sign-in at Scopus site)

Author List

Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA

Authors

Kwang Woo Ahn PhD Director, Professor in the Data Science Institute department at Medical College of Wisconsin
Larisa Broglie MD, MS Associate Professor in the Pediatrics department at Medical College of Wisconsin
Mary Eapen MBBS, DCh, MRCPI, MS Professor in the Medicine department at Medical College of Wisconsin
Julie-An M. Talano MD Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Antigens, CD34
Child
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Humans
Neuroblastoma
Peripheral Blood Stem Cell Transplantation
Transplantation, Autologous